President of R&D, Therapeutics
Mon, Apr 14, 2025
Apr 14
3,345 shares @ $2.92
Increased holdings by +11.50%
34th largest trade (out of 68)
Positive 90D History
Trade made by an officer
10b5-1 scheduled trade
100% win rate · +29.9% median edge vs SPY (22 trades, 90-day)
Insider trade was 89% below market price
Price 28% above 200-day moving average
Small Cap stock — insider trades carry more weight